Apixaban and Rifampin
Desk tier: Serious concern
Mechanism: strong CYP3A4 induction of clearance (↓ exposure / loss of efficacy)
“Avoid concomitant use of ELIQUIS with combined P-gp and strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin”
All pairs for Apixaban · Rifampin
Enzyme behind this pair: CYP3A4
Educational reference only. Not FDA-cleared. The Prescribing Information governs.